• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年脓毒症——新趋势及其对多发伤患者的影响

Sepsis 2019 - New Trends and Their Implications for Multiple Trauma Patients.

作者信息

Dickmann Petra, Bauer Michael

机构信息

Department of Anaesthesiology and Intensive Care, University Hospital Jena.

Center for Sepsis Control and Care (CSCC), University Hospital Jena.

出版信息

Z Orthop Unfall. 2020 Feb;158(1):81-89. doi: 10.1055/a-0853-2054. Epub 2019 Sep 9.

DOI:10.1055/a-0853-2054
PMID:31499573
Abstract

In spring 2016, an updated sepsis definition (Sepsis-3) introduced a new explanation for the clinical picture of sepsis. Until then, sepsis had been understood as a "systemic inflammatory response syndrome (SIRS)" resulting from infection. An improved understanding of the molecular mechanisms and broad epidemiological studies of the clinical appearance shifted the focus from the inflammatory response to the multicausal tissue damage resulting in organ dysfunction. This paradigm shift highlights organ failure as a result of a dysregulated response of an organism to infection. Central to the new definition is the understanding that sepsis patients form a heterogeneous group and that the clinical picture requires alternative explanation patterns: e.g. sepsis is insufficiently explained by an overwhelming inflammatory response, it also comprises "immune paralysis" as another important pattern. Furthermore, severity of sepsis reflects the capacity of an organism to adapt and to mitigate the tissue damage through metabolic changes and repair mechanisms. Consistent with the paradigm of the new sepsis definition, adaptation in the presence of infections is crucial for the organism. Seriously injured or multiple trauma patients represent a patient group at particular risk, as sepsis often complicates the courses of these patients due to nosocomial infections. Along with comorbidities, past infections and age, leakage of skin and intestinal barriers as well as impaired defence and repair mechanism predispose trauma patients for a septic course. New pathophysiological insights suggest that the control of extracellular haem is of paramount significance. Haemolysis, transfusion and the consecutive expression of haem binding (such as haemopexin) or haem catabolic pathways (such as haem oxygenase) impair the ability of an organism to adapt, correlate with the prognosis and/or are strongly influenced by the surgical treatment concepts. Established treatment concepts of early causal and supportive therapy (damage control, antibiotic and fluid therapy) contribute to the reduction of mortality, depending on stringent implementation as part of Standard Operating Procedures (SOPs) and quality management. The paradigm shift in sepsis research offers an improved understanding of the underlying pathogenic factors within complex and heterogeneous patient groups, such as nosocomial sepsis following trauma. These novel approaches will allow developing new treatment strategies potentially contributing to a significant reduction in morbidity and mortality of trauma patients.Key messages1) According to the new paradigm, the ability to adapt to the pathogenic load associated with trauma and infection is crucial for an organism.2) Seriously injured or multiple trauma patients are predisposed for septic courses due to impaired adaptation mechanisms.3) Established treatment concepts of early causal and supportive therapy (damage control, antibiotic treatment, restrictive transfusion, and volume resuscitation) reduce mortality, in particular as part of SOPs and quality management strategies.4) Newly emerging treatment concepts that focus on the control of extracellular haem are promising, but require more evidence for translation into clinical practice.

摘要

2016年春季,更新后的脓毒症定义(Sepsis-3)对脓毒症的临床表现给出了新的解释。在此之前,脓毒症一直被理解为由感染引起的“全身炎症反应综合征(SIRS)”。对分子机制的深入理解以及对临床表现的广泛流行病学研究,将焦点从炎症反应转移到了导致器官功能障碍的多因素组织损伤上。这种范式转变突出了机体对感染反应失调导致的器官衰竭。新定义的核心是认识到脓毒症患者构成一个异质性群体,其临床表现需要不同的解释模式:例如,脓毒症不能仅用压倒性的炎症反应来充分解释,它还包括“免疫麻痹”这一重要模式。此外,脓毒症的严重程度反映了机体通过代谢变化和修复机制进行适应并减轻组织损伤的能力。与新的脓毒症定义范式一致,感染时的适应能力对机体至关重要。严重受伤或多发伤患者是特别危险的患者群体,因为脓毒症常因医院感染而使这些患者的病程复杂化。除了合并症、既往感染和年龄外,皮肤和肠道屏障的渗漏以及防御和修复机制受损使创伤患者易发生脓毒症病程。新的病理生理学见解表明,细胞外血红素的控制至关重要。溶血、输血以及血红素结合(如血红素结合蛋白)或血红素分解代谢途径(如血红素加氧酶)的连续表达会损害机体的适应能力,与预后相关和/或受到手术治疗理念强烈影响。既定早期病因和支持性治疗(损伤控制、抗生素和液体治疗)的治疗理念有助于降低死亡率,这取决于作为标准操作规程(SOP)和质量管理一部分的严格实施。脓毒症研究中的范式转变有助于更好地理解复杂异质性患者群体(如创伤后医院获得性脓毒症)中的潜在致病因素。这些新方法将有助于开发新的治疗策略,可能显著降低创伤患者的发病率和死亡率。

关键信息

1)根据新范式,机体适应与创伤和感染相关致病负荷 的能力至关重要。

2)严重受伤或多发伤患者因适应机制受损而易发生脓毒症病程。

3)既定早期病因和支持性治疗(损伤控制、抗生素治疗、限制性输血和容量复苏)的治疗理念可降低死亡率,特别是作为SOP和质量管理策略的一部分。

4)专注于细胞外血红素控制的新兴治疗理念很有前景,但需要更多证据才能转化为临床实践。

相似文献

1
Sepsis 2019 - New Trends and Their Implications for Multiple Trauma Patients.2019年脓毒症——新趋势及其对多发伤患者的影响
Z Orthop Unfall. 2020 Feb;158(1):81-89. doi: 10.1055/a-0853-2054. Epub 2019 Sep 9.
2
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients.美国胸科医师学会/危重病医学会关于严重创伤患者的全身炎症反应综合征及相关病症的共识会议定义
Crit Care Med. 1997 Nov;25(11):1789-95. doi: 10.1097/00003246-199711000-00014.
3
[Epistemology in the intensive care unit-what is the purpose of a definition? : Paradigm shift in sepsis research].[重症监护病房中的认识论——定义的目的是什么?:脓毒症研究中的范式转变]
Anaesthesist. 2017 Aug;66(8):622-625. doi: 10.1007/s00101-017-0315-3.
4
[Significance of systemic inflammation in 1,278 trauma patients].[1278例创伤患者全身炎症反应的意义]
Unfallchirurg. 1998 Jul;101(7):520-6. doi: 10.1007/s001130050304.
5
The epidemiology of the systemic inflammatory response.全身炎症反应的流行病学
Intensive Care Med. 2000;26 Suppl 1(Suppl 1):S64-74. doi: 10.1007/s001340051121.
6
Effects of accidental hypothermia on posttraumatic complications and outcome in multiple trauma patients.意外低体温对多发创伤患者创伤后并发症和结局的影响。
Injury. 2013 Jan;44(1):86-90. doi: 10.1016/j.injury.2011.10.013. Epub 2011 Oct 30.
7
Implications of the new sepsis definition on research and practice.新的脓毒症定义对研究和实践的影响。
J Crit Care. 2017 Apr;38:259-262. doi: 10.1016/j.jcrc.2016.11.032. Epub 2016 Nov 24.
8
Resuscitation with polymeric plasma substitutes is permissive for systemic inflammatory response syndrome and sepsis in multiply injured patients: a retrospective cohort study.多部位创伤患者应用聚合型血浆代用品复苏可导致全身炎症反应综合征和脓毒症:一项回顾性队列研究。
Eur J Med Res. 2016 Oct 13;21(1):39. doi: 10.1186/s40001-016-0227-8.
9
Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.髓系细胞表面表达的可溶性触发受体-1参与多发伤后全身炎症反应综合征的证据。
J Trauma. 2008 Dec;65(6):1385-90. doi: 10.1097/TA.0b013e31814699cc.
10
[Physiopathology of severe sepsis].[严重脓毒症的病理生理学]
Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. doi: 10.1016/s0755-4982(04)98551-x.

引用本文的文献

1
Impact of trauma level designation on mortality in trauma patients with sepsis: an observational study across US trauma centers.创伤分级对脓毒症创伤患者死亡率的影响:一项美国创伤中心的观察性研究
Front Med (Lausanne). 2025 Aug 18;12:1591624. doi: 10.3389/fmed.2025.1591624. eCollection 2025.
2
Integrin α4β1/VCAM-1 Interaction Evokes Dynamic Cell Aggregation Between Immune Cells and Human Lung Microvascular Endothelial Cells at Infectious Hemolysis.整合素α4β1/血管细胞黏附分子-1相互作用在感染性溶血时引发免疫细胞与人类肺微血管内皮细胞之间的动态细胞聚集。
Front Pharmacol. 2021 Apr 20;12:653143. doi: 10.3389/fphar.2021.653143. eCollection 2021.
3
Advantage of surgical intensive care unit (SICU) predominant by cardiothoracic surgeons in multiple trauma management in a primary hospital.
心胸外科医师主导的外科重症监护病房(SICU)在基层医院多发创伤管理中的优势。
Chin J Traumatol. 2021 Feb;24(1):45-47. doi: 10.1016/j.cjtee.2020.11.004. Epub 2020 Nov 13.
4
Update on diagnosis and management of sepsis in cirrhosis: Current advances.肝硬化患者脓毒症的诊断与管理进展:当前研究进展
World J Hepatol. 2020 Aug 27;12(8):451-474. doi: 10.4254/wjh.v12.i8.451.
5
Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies.核酸纳米颗粒:疫苗与免疫疗法的十字路口
Molecules. 2019 Dec 17;24(24):4620. doi: 10.3390/molecules24244620.